
Axpero 1mg Tablet
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Axitinib (1mg)
Overview Axpero 1mg Tablet
Oncaspar 1mg tablets are a medication used to treat renal cell carcinoma. Administer this medication with or without food, consistently at the same time daily for optimal efficacy. Dosage and frequency are determined by your physician based on your individual needs and may be adjusted. Strictly adhere to your prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may take weeks or months to manifest; discontinue use only under your doctor's guidance. Common side effects include elevated blood pressure, arthralgia, and anorexia. Diarrhea and dyspnea can be serious; manage these as directed by your physician, including appropriate hydration. Regular blood pressure monitoring is typically recommended. Report severe headache, disorientation, visual disturbances, nausea, or vomiting immediately. Prior to initiating treatment, disclose any thyroid disorders, hepatic impairment, bleeding disorders, or use of antimicrobial agents. Numerous drug interactions are possible; inform your healthcare provider of all medications currently in use. This medication is contraindicated in pregnancy and lactation; effective contraception is crucial for female patients during treatment.
Uses of Axpero 1mg Tablet
Renal cell carcinoma
Major Benefits of Axpero 1mg Tablet:
Administer this medication precisely as prescribed by your physician, both in terms of dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Axpero 1mg tablets can be consumed with or without food, although consistent daily timing is recommended.
Common Side effects of Axpero 1mg Tablet:
- High blood pressure
- Joint pain
- Loss of appetite
- Diarrhea
- Breathing problems
- Abdominal pain
- Constipation
- Cough
- Decreased appetite
- Decreased level of thyroid hormones
- Difficulty in speaking
- Dry skin
- Indigestion
- Headache
- Nausea
- Pain in extremities
- Painful blisters on hands and feet
- Protein in urine
- Rash
- Breathlessness
- Stomatitis (Inflammation of the mouth)
- Taste change
- Vomiting
How to use Axpero 1mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Axpero 1mg Tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, though consistent timing is recommended.
How Axpero 1mg Tablet works:
Axpero 1mg tablets are prescribed for cancer treatment. Their mechanism of action involves inhibiting the activity of a faulty protein responsible for prompting cancerous cell proliferation, thus hindering or slowing tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Axpero 1mg Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Axpero 1mg tablets during pregnancy poses a confirmed risk to the fetus and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Axpero 1mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Axpero 1mg Tablet may cause drowsiness, blurred vision, and dizziness, reducing alertness. Driving is inadvisable if these effects are experienced.
KidneySAFE IF PRESCRIBED
Axpero 1mg tablets are suitable for use by individuals with kidney impairment. No alteration of the Axpero 1mg tablet dosage is necessary.
LiverCAUTION
Patients with liver impairment should use Axpero 1mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Data regarding Axpero 1mg tablet use in patients exhibiting severe hepatic dysfunction is limited.
What if you forget to take Axpero 1mg Tablet :
NA
Facts to Know About Axpero 1mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Indazole and Enzamide Derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Kinase inhibitors targeting tyrosine |
